FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113373161> ?p ?o ?g. }

• W2113373161 endingPage "3493" @default.
• W2113373161 startingPage "3483" @default.
• W2113373161 abstract "Abstract Patients with bilateral vestibular schwannomas associated with neurofibromatosis type 2 (NF2) experience significant morbidity such as complete hearing loss. We have recently shown that treatment with bevacizumab provided tumor stabilization and hearing recovery in a subset of NF2 patients with progressive disease. In the current study, we used two animal models to identify the mechanism of action of anti–vascular endothelial growth factor (VEGF) therapy in schwannomas. The human HEI193 and murine Nf2−/− cell lines were implanted between the pia and arachnoid meninges as well as in the sciatic nerve to mimic central and peripheral schwannomas. Mice were treated with bevacizumab (10 mg/kg/wk i.v.) or vandetanib (50 mg/kg/d orally) to block the VEGF pathway. Using intravital and confocal microscopy, together with whole-body imaging, we measured tumor growth delay, survival rate, as well as blood vessel structure and function at regular intervals. In both models, tumor vessel diameter, length/surface area density, and permeability were significantly reduced after treatment. After 2 weeks of treatment, necrosis in HEI193 tumors and apoptosis in Nf2−/− tumors were significantly increased, and the tumor growth rate decreased by an average of 50%. The survival of mice bearing intracranial schwannomas was extended by at least 50%. This study shows that anti-VEGF therapy normalizes the vasculature of schwannoma xenografts in nude mice and successfully controls the tumor growth, probably by reestablishing a natural balance between VEGF and semaphorin 3 signaling. Cancer Res; 70(9); 3483–93. ©2010 AACR." @default.
• W2113373161 created "2016-06-24" @default.
• W2113373161 creator A5015585176 @default.
• W2113373161 creator A5018467186 @default.
• W2113373161 creator A5019864381 @default.
• W2113373161 creator A5045177125 @default.
• W2113373161 creator A5053515304 @default.
• W2113373161 creator A5054359239 @default.
• W2113373161 creator A5059797681 @default.
• W2113373161 creator A5064644062 @default.
• W2113373161 date "2010-04-28" @default.
• W2113373161 modified "2023-10-14" @default.
• W2113373161 title "Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors" @default.
• W2113373161 cites W1558361583 @default.
• W2113373161 cites W1971959149 @default.
• W2113373161 cites W1973106770 @default.
• W2113373161 cites W1977887541 @default.
• W2113373161 cites W1989794271 @default.
• W2113373161 cites W1993016882 @default.
• W2113373161 cites W1997841789 @default.
• W2113373161 cites W2004781757 @default.
• W2113373161 cites W2006194604 @default.
• W2113373161 cites W2006202974 @default.
• W2113373161 cites W2014282546 @default.
• W2113373161 cites W2018161909 @default.
• W2113373161 cites W2020088894 @default.
• W2113373161 cites W2025726250 @default.
• W2113373161 cites W2028437938 @default.
• W2113373161 cites W2042349690 @default.
• W2113373161 cites W2052796007 @default.
• W2113373161 cites W2061340184 @default.
• W2113373161 cites W2067055586 @default.
• W2113373161 cites W2067888137 @default.
• W2113373161 cites W2073043640 @default.
• W2113373161 cites W2083045544 @default.
• W2113373161 cites W2083142752 @default.
• W2113373161 cites W2088971478 @default.
• W2113373161 cites W2090699402 @default.
• W2113373161 cites W2092299406 @default.
• W2113373161 cites W2096643761 @default.
• W2113373161 cites W2100694891 @default.
• W2113373161 cites W2101817039 @default.
• W2113373161 cites W2109134893 @default.
• W2113373161 cites W2109837044 @default.
• W2113373161 cites W2114550587 @default.
• W2113373161 cites W2117713501 @default.
• W2113373161 cites W2118559000 @default.
• W2113373161 cites W2128687105 @default.
• W2113373161 cites W2147535764 @default.
• W2113373161 cites W2150706412 @default.
• W2113373161 cites W2157268627 @default.
• W2113373161 cites W2157774521 @default.
• W2113373161 cites W2170249858 @default.
• W2113373161 cites W49002905 @default.
• W2113373161 doi "https://doi.org/10.1158/0008-5472.can-09-3107" @default.
• W2113373161 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4785015" @default.
• W2113373161 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20406973" @default.
• W2113373161 hasPublicationYear "2010" @default.
• W2113373161 type Work @default.
• W2113373161 sameAs 2113373161 @default.
• W2113373161 citedByCount "93" @default.
• W2113373161 countsByYear W21133731612012 @default.
• W2113373161 countsByYear W21133731612013 @default.
• W2113373161 countsByYear W21133731612014 @default.
• W2113373161 countsByYear W21133731612015 @default.
• W2113373161 countsByYear W21133731612016 @default.
• W2113373161 countsByYear W21133731612017 @default.
• W2113373161 countsByYear W21133731612018 @default.
• W2113373161 countsByYear W21133731612019 @default.
• W2113373161 countsByYear W21133731612020 @default.
• W2113373161 countsByYear W21133731612021 @default.
• W2113373161 countsByYear W21133731612022 @default.
• W2113373161 countsByYear W21133731612023 @default.
• W2113373161 crossrefType "journal-article" @default.
• W2113373161 hasAuthorship W2113373161A5015585176 @default.
• W2113373161 hasAuthorship W2113373161A5018467186 @default.
• W2113373161 hasAuthorship W2113373161A5019864381 @default.
• W2113373161 hasAuthorship W2113373161A5045177125 @default.
• W2113373161 hasAuthorship W2113373161A5053515304 @default.
• W2113373161 hasAuthorship W2113373161A5054359239 @default.
• W2113373161 hasAuthorship W2113373161A5059797681 @default.
• W2113373161 hasAuthorship W2113373161A5064644062 @default.
• W2113373161 hasBestOaLocation W21133731611 @default.
• W2113373161 hasConcept C126322002 @default.
• W2113373161 hasConcept C142724271 @default.
• W2113373161 hasConcept C167734588 @default.
• W2113373161 hasConcept C2776694085 @default.
• W2113373161 hasConcept C2777025900 @default.
• W2113373161 hasConcept C2777802072 @default.
• W2113373161 hasConcept C2778679214 @default.
• W2113373161 hasConcept C2778984943 @default.
• W2113373161 hasConcept C509974204 @default.
• W2113373161 hasConcept C71924100 @default.
• W2113373161 hasConceptScore W2113373161C126322002 @default.
• W2113373161 hasConceptScore W2113373161C142724271 @default.
• W2113373161 hasConceptScore W2113373161C167734588 @default.
• W2113373161 hasConceptScore W2113373161C2776694085 @default.
• W2113373161 hasConceptScore W2113373161C2777025900 @default.

• next